CXC-chemokines in coronary artery disease: Possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 2, 2003, Pages 257-262

  Holm, T ^a   Damas J K ^a   Holven, K ^a   Nordoy I ^a   Brosstad, F R ^a   Ueland, T ^a   Wahre T ^a   Kjekshus, J ^a   Froland S S ^a   Eiken, H G ^a   Solum, N O ^a   Gullestad, L ^a   Nenseter, M ^a   Aukrust, P ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Atherosclerosis; Chemokines; Leukocytes; Lipids; Platelets

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE; CHEMOTACTIC FACTOR; CXCL1 PROTEIN, HUMAN; CXCL5 PROTEIN, HUMAN; DRUG DERIVATIVE; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; SIGNAL PEPTIDE;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MONONUCLEAR CELL; PHYSIOLOGY; RISK FACTOR; THROMBOCYTE;

ADULT; AGED; ARTERIOSCLEROSIS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CHEMOKINES; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; CORONARY ARTERIOSCLEROSIS; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; RISK FACTORS; RNA, MESSENGER;

EID: 0141785273     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00065.x     Document Type: Article

References (27)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Ross R. The pathogenesis of atheroscleosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
3. Terkeltaub R, Banka CL, Solan J, Santoro D, Brand K, Curtiss LK. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb 1994; 14: 47-53.
4. Theilmeier G, Lenaerts T, Remacle C, Collen D, Vermylen J, Hoylaerts MF. Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress. Blood 1999; 94: 2725-34.
5. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster, R, Muller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-4.
6. Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Frøland SS, Gullestad L. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 1999; 100: 614-20.
7. Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997; 349: 490-5.
8. BoisvertWA, Curtiss LK, Terkeltaub RA. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 2000; 21: 129-37.
9. Terkeltaub R, Boisvert WA, Curtiss LK. Chemokines and atherosclerosis. Cur Opin Lipidol 1998; 9: 397-405.
10. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 1998; 101: 353-63.
11. Aukrust P, Müller F, Frøland SS. Enhanced generation of reactive oxygen species in monocytes from patients with common variable immunodeficiency. Clin Exp Immunol 1994; 97: 232-8.
12. Holme PA, Müller F, Solum NO, Brosstad F, Frøland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J 1998; 12: 79-89.
13. Knofler R, Weissbach G, Kuhlisch E. Release of adenosine triphosphate by adenosine diphosphate in whole blood and in erythrocyte suspensions. Am J Hematol 1997; 56: 259-65.
14. Damås JK, Eiken HG, Øie E, Bjerkeli V, Yndestad A, Ueland T, Tønnessen T, Geiran OR, Aass H, Simonsen S, Christensen G, Frøland SS, Attramadal H, Gullestad L, Aukrust P. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res 2000; 47: 778-87.
15. Damås JK, Gullestad L, Ueland T, Solum NO, Simonsen S, Frøland SS, Aukrust P. CXC-chemokines, a new group of cytokines in congestive heart failure - possible role of platelets and monocytes. Cardiovasc Res 2000; 45: 428-36.
16. Janabi M, Yamashita S, Hirano K, Sakai N, Hiraoka H, Matsumoto K, Zhang Z, Nozaki S, Matsuzawa Y. Oxidized LDL-induced NF-kB activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol 2000; 20: 1953-60.
17. Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC, Hama S, Borromeo C, Evans RM, Berliner JA, Nagy L. Role for peroxisome proliferator-activated receptor a in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-by endothelial cells. Circ Res 2000; 87: 516-21.
18. Sindermann JR, Schmidt A, Breithardt G. Upregulation of the interleukin-system in hypercholesterolemic patients. Does inhibition of the mevalonate pathway lower interleukin-8 levels in the vessel wall? Atherosclerosis 2000; 150: 443-4.
19. EsslerM, RetzerM, Bauer M, Zangl KJ, Tigyi G, SiessW. Stimulation of platelets and endothelial cells by mildly oxidized LDL proceeds through activation of lysophosphatidic acid receptors and the Rho/Rho-kinase pathway. Inhibition by lovastatin. Ann N Y Acad Sci 2000; 905: 282-6.
20. SiessW, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 1999; 96: 6931-6.
21. 2+ influx in human platelets. J Biol Chem 2000; 275: 19159-66.
22. Chen M, Kakutani M, Naruko T, Ueda M, Narumiya S, Masaki T, Sawamura T. Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun 2001; 282: 153-8.
23. Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000; 101: 2889-95.
24. Volf I, Bielek E, Moeslinger T, Koller F, Koller E. Modification of protein moiety of human low density lipoprotein by hypochlorite generates strong platelet agonist. Arterioscler Thromb Vasc Biol 2000; 20: 2011-8.
25. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97: 1525-34.
26. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999; 34: 1420-6.
27. Johnsen CR, Chapman SM, Dong ZM, Ordovas JM, Mayadas TN, Herz J, Hynes RO, Schaefer EJ, Wagner DD. Absence of P-selectin delays fatty streak formation in mice. Circulation 2000; 99: 1037-43.